NASDAQ: CNTA

CNTA’s price-to-sales ratio: Is it a good investment opportunity?
Cameron Mitchell
Centessa Pharmaceuticals plc ADR (CNTA)’s stock has witnessed a price declined of -1.81% from the previous close with its current ...

Centessa Pharmaceuticals plc ADR (CNTA)’s stock has witnessed a price declined of -1.81% from the previous close with its current ...